Related Experiment Videos
[New advances in the knowledge on post-thrombotic syndrome]
F Gabriel Botella1, M Labiós Gómez, O Portolés Reparaz
1Servicio de Medicina Interna, Hospital Clínico Universitario de Valencia.
Summary
Post-thrombotic syndrome (PTS) affects 17-50% of patients after deep venous thrombosis (DVT), leading to chronic venous insufficiency. Early diagnosis and treatment are crucial for managing this condition.
Area of Science:
- Vascular Medicine and Surgery
- Hematology
- Medical Imaging
Context:
- Post-thrombotic syndrome (PTS) incidence remains uncertain, estimated between 17% and 50% one year after acute deep venous thrombosis (DVT) of the lower limbs.
- PTS is characterized by venous hypertension, valvular incompetence, and inflammatory reactions involving endothelial permeability, leukocyte adhesion, and tissue fibrosis.
- Risk factors for PTS are poorly understood, with recurrent DVT being the only identified factor to date.
Purpose:
- To review the current understanding of post-thrombotic syndrome (PTS) following deep venous thrombosis (DVT).
- To discuss diagnostic modalities, including clinical scales, Echo-Doppler, and emerging imaging techniques.
- To outline therapeutic strategies, encompassing pharmacological and surgical interventions.
Summary:
- Echo-Doppler is the primary non-invasive tool for diagnosing valvular dysfunction and chronic venous obstruction in PTS.
- Advanced imaging like CT, MR, and isotopic techniques show promise but require further validation.
- Phlebothropic drugs are the mainstay for non-surgical PTS management, while deep venous surgery is reserved for severe chronic venous insufficiency with significant reflux.
Impact:
- Improved diagnostic accuracy through advanced imaging may lead to earlier intervention.
- Optimized therapeutic strategies can mitigate the progression of chronic venous insufficiency and improve patient outcomes.
- Further research into PTS risk factors is needed to enhance preventative measures.